Cargando…
Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect
COVID-19 has emerged as a major cause of health crisis around the world. Psychosocial, Behavioral and metabolic changes especially weight gain, among variety of population was produced in this pandemic, through variety of mechanisms. Hyperlipidemia is one of the major issues that result in serious c...
Autores principales: | Preethi, L., Ganamurali, Nila, Dhanasekaran, Dhivya, Sabarathinam, Sarvesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081575/ https://www.ncbi.nlm.nih.gov/pubmed/33942025 http://dx.doi.org/10.1016/j.obmed.2021.100346 |
Ejemplares similares
-
Junk food-induced obesity- a growing threat to youngsters during the pandemic
por: Singh S, Ankul, et al.
Publicado: (2021) -
Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required?
por: Sabarathinam, Sarvesh, et al.
Publicado: (2023) -
An exploration of the experience of dapagliflozin in clinical practice
por: Anitha, Anuba Paulvarnan, et al.
Publicado: (2022) -
The role of guggulsterone on the NF-κB pathway in inflammatory bowel disease: preclinical evidence
por: Priya, SK Sujitha, et al.
Publicado: (2022) -
“Covibesity,” a new pandemic
por: Khan, Moien AB, et al.
Publicado: (2020)